M&A activity in the pharmaceutical industry in Italy increased in 2023

In value terms, M&A activity in Italy remained flat in Q2 2023 compared with the previous quarter and as compared to Q2 2022. Related deal volume increased by 40% in Q2 2023 versus the previous quarter and was 40% higher than in Q2 2022.

The top-ranked legal advisorss supporting these M&A deals in Italy Q2 2023 were BonelliErede; CMS Legal Services EEIG; CMS Legal Services EEIG – France with 1, 1, 1 deals respectively.

For further understanding of GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.

This content was updated on 18 July 2023

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.

Surveillance Still Not an Option for Many With Subsegmental Pulmonary Embolism

Only a narrow pool of outpatients with acute subsegmental pulmonary embolism (PE) may be candidates for structured surveillance without anticoagulation based on current guideline restrictions,

August 4, 2023

Study sheds light on how deep sleep supports memory formation

It has been known for nearly 20 years that slow, synchronous electrical waves in the brain during deep sleep support the formation of memories.

December 12, 2024

Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit

Treatment with an experimental CAR-T therapy for multiple myeloma from Arcellx and Gilead Sciences resulted in zero cases of delayed neurotoxicity, including Parkinsonian symptoms and

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.